Article ; Online: Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age.
2011 Volume 158, Issue 5, Page(s) 759–765.e1
Abstract: Objective: To examine the long-term effects of fluconazole prophylaxis in extremely low birth weight infants.: Study design: Neurodevelopmental status and quality of life of survivors from a randomized, placebo-controlled trial of fluconazole ... ...
| Abstract | Objective: To examine the long-term effects of fluconazole prophylaxis in extremely low birth weight infants. Study design: Neurodevelopmental status and quality of life of survivors from a randomized, placebo-controlled trial of fluconazole prophylaxis were evaluated at 8 to 10 years of life using the Vineland Adaptive Behavior Scales-II (VABS-II) and the Child Health Questionnaire Parent-Completed Form 28 (CHQ-PF28), respectively. Results: VABS-II Domain Scores for the fluconazole-treated (n = 21; 9.1 ± 0.7 years) compared with the placebo group (n = 17; 9.3 ± 0.8 years) were similar for communication [94.6 (±14.8) versus 92.6 (±12.6), P = .65], daily living skills [87.9 (±10.6) versus 87.4 (±9.3), P = .89], socialization [97.2 (±9.2) versus 94.4 (±7.9), P = .31], and motor skills [92.1 (±17.8) versus 95.1 (±14.6), P = .57]. Internalizing and externalizing behaviors and maladaptive behavior index were also similar. The CHQ-PF28 revealed no differences between the two groups regarding quality of life. Survivors were also happy or satisfied with school (90% versus 100%, P = .49), friendships (90% versus 88%, P = 1.00), and life (95% versus 100%, P = 1.00). Self esteem scores were 87.3 ± 15.7 versus 89.7 ± 10.4 (P = .59). There were also no differences between groups regarding emotional difficulties or behavior problems. Conclusions: Fluconazole prophylaxis for the prevention of invasive Candida infections is safe in extremely low birth weight infants and does not appear to be associated with any long-term adverse effects on neurodevelopment and quality of life at 8 to 10 years of life. |
|---|---|
| MeSH term(s) | Antifungal Agents/therapeutic use ; Candidiasis/prevention & control ; Child ; Developmental Disabilities/prevention & control ; Double-Blind Method ; Female ; Fluconazole/therapeutic use ; Follow-Up Studies ; Humans ; Infant, Extremely Low Birth Weight ; Infant, Newborn ; Male ; Prospective Studies ; Quality of Life ; Time Factors ; Treatment Outcome |
| Chemical Substances | Antifungal Agents ; Fluconazole (8VZV102JFY) |
| Language | English |
| Publishing date | 2011-05 |
| Publishing country | United States |
| Document type | Comparative Study ; Journal Article ; Randomized Controlled Trial |
| ZDB-ID | 3102-1 |
| ISSN | 1097-6833 ; 0022-3476 |
| ISSN (online) | 1097-6833 |
| ISSN | 0022-3476 |
| DOI | 10.1016/j.jpeds.2010.11.002 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Um IV Zs.116: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.